Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Therapy for the Primary and Secondary Prevention of Heart Failure in Patients With and Without Type 2 Diabetes Mellitus: A Systematic Review

The global prevalence of heart failure (HF) is rising and carries a heavy social and economic burden. Type 2 diabetes mellitus (T2DM) patients are at an increased risk of incident HF even in the absence of cardiovascular risk factors. Patients with established HF are at an increased risk of death fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahinya, Maureen, Khan, Zahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171706/
https://www.ncbi.nlm.nih.gov/pubmed/37181972
http://dx.doi.org/10.7759/cureus.37388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171706/
https://www.ncbi.nlm.nih.gov/pubmed/37181972
http://dx.doi.org/10.7759/cureus.37388

Ejemplares similares